Table 1

Psoriasin expression and clinical/pathological characteristics of lung cancer
Clinical/pathological features Sample no. Median (Copy no.) IQR P-value
Tumour tissue 83 0.17 0-27.5
Background tissue 69 0.01 0-1 0.0195
Paired tumour tissue 61 0.17 0-24.1
Paired background tissue 61 0.01 0-1 0.0251
Gender
Male 47
Female 25
Histology
Squamous carcinoma 30 0.4 0-45
Adenocarcinoma 37 0.1 0-4.1 0.035
Others 6 N/A N/A
TNM staging
I 22 0 0-15.3
II 16 0.1 0-110.8 0.22
III 34 1 0-43 0.085
Tumour differentiation
High 5 0.1 0-27.2
Med 33 1 0-42 0.17
Low 11 0.01 0-1.15 0.51
Tumour status
T1 8 3.99 0-13.87
T2 41 0 0-22.2 0.989
T3 23 25.6 0-225.6 0.081
Lymph node status
N0 24 0 0-18
N1 13 0.1 0-77.6 0.93
N2 25 1 0-42 0.51
Smoking status
Former or current smoker 49 0.2 0-43
Non smoker 23 0 0-12 0.0372

Hu et al.

Hu et al. BMC Cancer 2012 12:588   doi:10.1186/1471-2407-12-588

Open Data